Targeted Approaches News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Targeted approaches. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Targeted Approaches Today - Breaking & Trending Today

Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Senhwa Biosciences’s Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium
December 14, 2020 GMT
TAIPEI and SAN DIEGO, Dec. 13, 2020 /PRNewswire/ Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced their Abstract on Cholangiocarcinoma treatment with Silmitasertib (CX-4945) has been accepted for oral/poster presentation at the upcoming American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) in San Francisco, 15-17 January, 2021. Due to the COVID-19 pandemic, the event will be hosted virtually. ....

United States , T Ai Pei , San Diego , San Francisco , Senhwa Biosciences , Senhwa Biosciences Inc , Prnewswire Senhwa Biosciences Inc , American Society , Poster Highlights , Targeted Approaches , Orphan Drug Designation , Rare Pediatric Disease Designation , ஒன்றுபட்டது மாநிலங்களில் , டி ஐ பேய் , சான் டியாகோ , சான் பிரான்சிஸ்கோ , அமெரிக்கன் சமூகம் , போஸ்டர் சிறப்பம்சங்கள் , ஆர்ஃபந் மருந்து பதவி , ரேர் குழந்தை நோய் பதவி ,